http://purl.uniprot.org/citations/12810606 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/12810606 | http://www.w3.org/2000/01/rdf-schema#comment | "BackgroundInsulin resistance is associated with atherosclerosis, but its mechanism is unknown. It has been reported that insulin receptor substrate (IRS)-1 deficient (IRS-1-/-) mice showed insulin resistance without type 2 diabetes, whereas the IRS-2 deficient (IRS-2-/-) mice showed insulin resistance with type 2 diabetes.Methods and resultsWe investigated neointima formation in the IRS-1-/- and IRS-2-/- mice at 8 and 20 weeks. The IRS-2-/-mice showed much greater neointima formation than the IRS-1-/- and wild-type mice at 8 weeks. At 20 weeks, the IRS-2-/-mice had greater neointima formation than the IRS-1-/-mice, which showed more enhanced neointima formation than the wild-type mice. The IRS-1-/- and IRS-2-/-mice had dyslipidemia, hypertension, and insulin resistance. The IRS-2-/-mice had more metabolic abnormalities than the IRS-1-/-mice at 8 and 20 weeks. IRS-2 expression was detected, but IRS-1 expression was not detected in the vessels.ConclusionsThe neointima formation in the IRS-1-/- and IRS-2-/-mice appears to be related to abnormalities induced by the altered metabolic milieu in insulin-resistant states. Moreover, because neointima formation was much greater in the IRS-2-/- mice than in the IRS-1-/-mice at 8 and 20 weeks, it is suggested that a lack of IRS-2 renders the vasculature more susceptible to injury in the abnormal metabolic milieu, and IRS-2 may have a protective effect on neointima formation. We conclude that IRS-2 is protective and retards the development of neointima formation in insulin-resistant states."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.org/dc/terms/identifier | "doi:10.1161/01.cir.0000070937.52035.25"xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Kobayashi T."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Aizawa S."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Yamaguchi T."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Kadowaki T."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Kubota T."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Suzuki R."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Kamata K."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Kubota N."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Nagai R."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Terauchi Y."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Tobe K."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Moroi M."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/author | "Namiki A."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/date | "2003"xsd:gYear |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/name | "Circulation"xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/pages | "3073-3080"xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/title | "Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury."xsd:string |
http://purl.uniprot.org/citations/12810606 | http://purl.uniprot.org/core/volume | "107"xsd:string |
http://purl.uniprot.org/citations/12810606 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/12810606 |
http://purl.uniprot.org/citations/12810606 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/12810606 |
http://purl.uniprot.org/uniprot/#_P35569-mappedCitation-12810606 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/12810606 |
http://purl.uniprot.org/uniprot/#_O88970-mappedCitation-12810606 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/12810606 |